RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ORTEGA C
Collezione AO Ordine Mauriziano

Items : 11

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.

2024
ASL Città di Torino
AO Cuneo
ASL Asti
ASL Cuneo 2
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Maio MD; Tucci M; Ortega C; Vellani G; Rossi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; Ruatta F; Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Cattrini C; Vignani F; Dionisio R; Icardi M; et alii...

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Di Prima L; Ortega C; Audisio M; Audisio A; Turco F; Parlagreco E; Ungaro A; Di Stefano RF; Tucci M;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.

2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; Scagliotti GV; Di Maio M; Ortega C; Audisio M; Buttigliero C; Ungaro A; Turco F; Tucci M; Di Stefano RF; Audisio A; Delcuratolo MD;

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2020 Mar;40(3):704-711. doi: 10.1111/liv.14314. Epub 2019 Dec 11.

2020
ASL Cuneo 2
ASL Biella
AOU Città della Salute di Torino
AO Ordine Mauriziano

Casadei-Gardini A; Aprile G; Roviello G; Scartozzi M; Cascinu S; Silvestris N; Spallanzani A; Santini D; Gelsomino F; Depetris I; Cagnazzo C; Lombardi P; Fenocchio E; Sperti E; Di Maio M; Ortega C; Fornaro L; Aglietta M; Leone F; Cerma K; Salani F; Caputo F; Vivaldi C; Filippi R; Salati M;

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. in Clinical and translational allergy / Clin Transl Allergy. 2018 Oct 25;8:45. doi: 10.1186/s13601-018-0227-6. eCollection 2018.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Bousquet J; Arnavielhe S; Bedbrook A; Bewick M; Laune D; Mathieu-Dupas E; Murray R; Onorato GL; Pépin JL; Picard R; Portejoie F; Costa E; Fonseca J; Lourenço O; Morais-Almeida M; Todo-Bom A; Cruz AA; da Silva J; Serpa FS; Illario M; Menditto E; Cecchi L; Monti R; Napoli L; Ventura MT; De Feo G; Larenas-Linnemann D; Fuentes Perez M; Huerta Villabolos YR; et alii...

Assessment of prognostic factors in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA) after docetaxel (DOC) in Journal of Clinical Oncology

2016
AO Ordine Mauriziano

Cavaliere C; Caffo O; Ortega C; D'aniello C; Di Napoli M; Cecere SC; Della Pepa C; Crispo A; Maines F; Ruatta F; Iovane G; Montella M; Pignata S; Facchini G;

Sequential administration of new agents (NAs) after docetaxel (DOC) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Impact of disease control (DC) duration in second line on the subsequent line outcomes in Journal of Clinical Oncology

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Maines F; De Giorgi U; Facchini G; Fratino L; Gasparro D; Alesini D; Basso U; Tucci M; Ortega C; Scagliarini S; Verderame F; Barni S; D'Angelo A; Vicario G; Donini M; Carrozza F; Sava T; Sirotova Z; Santini D; Caffo O;

Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor to predict overall survival in Journal of Clinical Oncology

2016
AO Ordine Mauriziano

Cavaliere C; Caffo O; Ortega C; D'aniello C; Cecere SC; Di Napoli M; Della Pepa C; Crispo A; Maines F; Ruatta F; Iovane G; Montella M; Pignata S; Facchini G;

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) after a long-term disease control (LTDC) with abiraterone acetate (AA) or enzalutamide (ENZ) post docetaxel (DOC): Preliminary results from a multicenter Italian study in Journal of Clinical Oncology

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Veccia A; De Giorgi U; Facchini G; Fratino L; Gasparro D; Alesini D; Basso U; Tucci M; Ortega C; Scagliarini S; Verderame F; Lo Re G; Procopio G; Sabbatini R; Campadelli E; Zucali PA; Morelli F; Sartori D; Conteduca V; Caffo O;

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. in PloS one / PLoS One. 2013 Dec 30;8(12):e83026. doi: 10.1371/journal.pone.0083026. eCollection 2013.

2013
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sabbatini R; Maiello E; Adamo V; Tanca FM; Fedeli SL; Badalamenti G; Russo A; Collovà E; Satolli MA; Silvestris N; Santoni M; Virzì V; Lanzetta G; Carteni G; Ottaviani D; Ortega C; Vincenzi B; Berardi R; Berruti A; Fontana A; Mazzara C; Barni S; Porta C; Ibrahim T; Procopio G; Santini D; Felici A; Cinieri S; Tonini G; et alii...

Clinical outcome (CO) and predictive factors (PRE) evaluation of young ( 60 years) castration-resistant prostate cancer (CRPC) patients, treated with docetaxel (DOC): Preliminary results of an Italian multicenter retrospective study (CYCLOP study) in Journal of Clinical Oncology

2013
AO Ordine Mauriziano

Caffo O; Ortega C; Di Lorenzo G; Russa FL; Burgio SL; Messina C; Facchini G; Iacovelli R; Lodde M; Morelli F; Massari F; Procopio G; Zustovich F; Re GL; Pegoraro C; Gamucci T; Pappagallo GL; Veccia A; Maines F; Galligioni E;